What is Proton Therapy

Call Now For More Information

General Questions or
Schedule an Appointment

1-855-528-7248

Current Patients

1-206-306-2800

Physician Line

1-888-987-7782

Clinical Studies

Filter By:

A prospective feasibility study of respiratory-gated proton beam therapy for liver tumors Hong TS1, DeLaney TF2, Mamon HJ3, Willett CG4, Yeap BY5, Niemierko A2, Wolfgang JA2, Lu HM2, Adams J2, Weyman EA2, Arellano RS6, Blaszkowsky LS5, Allen JN5, Tanabe KK7, Ryan DP5, Zhu AX5. Gastrointestinal Cancers Read Study
A dosimetric comparison of proton and photon therapy in unresectable cancers of the head of pancreas Thompson RF, Mayekar SU, Zhai H, Both S, Apisarnthanarax S, Metz JM, Plastaras JP, Ben-Josef E Gastrointestinal Cancers Read Study
A comprehensive dosimetric study of pancreatic cancer treatment using three-dimensional conformal radiation therapy (3DCRT), intensity-modulated radiation therapy (IMRT), volumetric-modulated radiation therapy (VMAT), and passive-scattering and modulated-scanning proton therapy (PT) Ding X1, Dionisi F1, Tang S1, Ingram M1, Hung CY1, Prionas E1, Lichtenwalner P1, Butterwick I1, Zhai H1, Yin L1, Lin H1, Kassaee A1, Avery S Gastrointestinal Cancers Read Study
Proton therapy in adjuvant treatment of gastric cancer: Planning comparison with advanced x-ray therapy and feasibility report. Dionisi F1, Avery S, Lukens JN, Ding X, Kralik J, Kirk M, Roses RE, Amichetti M, Metz JM, Plastaras JP. Gastrointestinal Cancers Read Study
Is there a role for proton therapy in the treatment of hepatocellular carcinoma? A systematic review Dionisi F1, Widesott L2, Lorentini S3, Amichetti M Gastrointestinal Cancers Read Study
Protons offer reduced bone marrow, small bowel, and urinary bladder exposure for patients receiving neoadjuvant radiotherapy for resectable rectal cancer. Colaco RJ, Nichols RC, Huh S, Getman N, Ho MW, Li Z, Morris CG, Mendenhall WM, Mendenhall NP, Hoppe BS. Gastrointestinal Cancers Read Study
Clinical outcomes and toxicity of proton beam therapy for advanced cholangiocarcinoma Makita C1, Nakamura T, Takada A, Takayama K, Suzuki M, Ishikawa Y, Azami Y, Kato T, Tsukiyama I, Kikuchi Y, Hareyama M, Murakami M, Fuwa N, Hata M, Inoue T. Gastrointestinal Cancers Read Study
RE: Takatori K, Terashima K, Yoshida R, Horai A, Satake S, Ose T, Kitajima N, Kinoshita Y, Demizu Y, Fuwa N. Upper gastrointestinal complications associated with gemcitabine-concurrent proton radiotherapy for inoperable pancreatic cancer. J Gastroenterol. 2013; (E-pub only) Nichols RC Jr, Hoppe BS. Gastrointestinal Cancers Read Study
A phase I study on combined therapy with proton-beam radiotherapy and in situ tumor vaccination for locally advanced recurrent hepatocellular carcinoma Abei M, Okumura T, Fukuda K, Hashimoto T, Araki M, Ishige K, Hyodo I, Kanemoto A, Numajiri H, Mizumoto M, Sakae T, Sakurai H, Zenkoh J, Ariungerel G, Sogo Y, Ito A, Ohno T, Tsuboi K. Gastrointestinal Cancers Read Study
Downstaging of hepatocellular carcinoma using external beam radiotherapy with subsequent liver transplantation: A case report Wigg A, Hon K, Mosel L, Sladden N, Palumbo K. Gastrointestinal Cancers Read Study
Upper gastrointestinal complications associated with gemcitabine-concurrent proton radiotherapy for inoperable pancreatic cancer Takatori K, Terashima K, Yoshida R, Horai A, Satake S, Ose T, Kitajima N, Kinoshita Y, Demizu Y, Fuwa N. Gastrointestinal Cancers Read Study
Integrated peripheral boost in preoperative radiotherapy for the locally most advanced non-resectable rectal cancer patients Radu C, Norrlid O, Brændengen M, Hansson K, Isacsson U, Glimelius B. Gastrointestinal Cancers Read Study
Proton therapy with concomitant capecitabine for pancreatic and ampullary cancers is associated with a low incidence of gastrointestinal toxicity Nichols RC Jr, George TJ, Zaiden RA Jr, Awad ZT, Asbun HJ, Huh S, Ho MW, Mendenhall NP, Morris CG, Hoppe BS. Gastrointestinal Cancers Read Study
Dose-volume histogram analysis for risk factors of radiation-induced rib fracture after hypofractionated proton beam therapy for hepatocellular carcinoma Kanemoto A, Mizumoto M, Okumura T, Takahashi H, Hashimoto T, Oshiro Y, Fukumitsu N, Moritake T, Tsuboi K, Sakae T, Sakurai H. Gastrointestinal Cancers Read Study
What is the appropriate size criterion for proton radiotherapy for hepatocellular carcinoma? A dosimetric comparison of spot-scanning proton therapy versus intensity-modulated radiation therapy Toramatsu C, Katoh N, Shimizu S, Nihongi H, Matsuura T, Takao S, Miyamoto N, Suzuki R, Sutherland K, Kinoshita R, Onimaru R, Ishikawa M, Umegaki K, Shirato H. Gastrointestinal Cancers Read Study
Compensation method for respiratory motion in proton treatment planning for mobile liver cancer Jeong H, Lee SB, Yoo SH, Lim YK, Kim TH, Park S, Chai GY, Kang KM, Shin D. Gastrointestinal Cancers Read Study